Tianxin Yang

Tianxin Yang, MD, PhD

Languages spoken: English

Academic Information

Departments , Primary - Internal Medicine

Divisions: Nephrology & Hypertension

Academic Office Information

tianxin.yang@hsc.utah.edu

Research Interests

  • Renal Physiology
  • Hypertension, Renal

Education History

Postdoctoral Fellowship University of Michigan
 Postdoctoral Fellow
Tokyo Medical and Dental University
 PhD
Residency Peking Union Medical College
 Resident
Sun Yat-sen University of Medical Sciences
 MD

Selected Publications

Patent

  1. Yang T (2019). The use of nitrated lipids for treatment of side effects of toxic medical therapy. U.S. Patent No. Serial# 61/073,945. Washington, D.C.:U.S. Patent and Trademark Office.
  2. Yang T (2019). The use of nitrated lipids for treatment of obesity and obesity-related conditions. U.S. Patent No. Serial# 61/046,008. Washington, D.C.:U.S. Patent and Trademark Office.
  3. Yang T (2019). The use of prostaglandin E inhibitors for the treatment of the side effects of a toxic medical therapy. U.S. Patent No. Serial# 083404-0160. Washington, D.C.:U.S. Patent and Trademark Office.
  4. Yang T (2019). Methods for treatment of inflammatory diseases. U.S. Patent No. 61/089354. Washington, D.C.:U.S. Patent and Trademark Office.
  5. T. Yang (2016). Use of urinary (Pro)renin receptor as biomaker of kidney disease. U.S. Patent No. 62/095949. Washington, D.C.:U.S. Patent and Trademark Office.
  6. T. Yang (2016). Combination therapy with nitrated lipids and inhibitors of the renin-angiotension-aldosterone system (licensed to Complexa). U.S. Patent No. 61/525,543. Washington, D.C.:U.S. Patent and Trademark Office.
  7. T. Yang (2016). Compositions and methods of use for (pro)renin receptor antagonists. U.S. Patent No. 14-449,714. Washington, D.C.:U.S. Patent and Trademark Office.